Media Coverage

Australian diagnostics firm Proteomics International said Wednesday that it has expanded its researc...

Diagnostics trailblazer Proteomics International Laboratories has inked an expanded research deal wi...

Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 Sep...

Proteomics International Laboratories has received a milestone seal of approval for its industrial-s...

Research conducted at QIMR Berghofer has been commercialised into a product, to be launched in Brisb...

Cutting-edge technology being applied to the diagnosis, monitoring and treatment of injury and illne...

Proteomics International is on track to deliver a world-first simple blood test in Australia this ye...

Proteomics International is on the verge of releasing its groundbreaking PromarkerD diabetes-related...

Proteomics International will expand its Perth facility into a national diagnostics hub using a $6 m...

In a milestone moment, ASX-listed diagnostics innovator Proteomics International Laboratories has ac...

Getting a diagnosis of endometriosis could soon be much simpler with news a blood test is close to b...

IT AFFECTS one in ten women, causes severe pain and can reduce the chances of having a child. And ye...

Newly published results from ASX-listed diagnostics trailblazer Proteomics International Laboratorie...

Dr Richard Lipscombe from Proteomics International (ASX:PIQ) shares their new non-invasive diagnosti...

Having produced more positive diagnostics results, Proteomics plans to launch its PromarkerEndo devi...

ASX-listed diagnostics innovator Proteomics International Laboratories plans to start a commercial r...

Hi, it’s Lisa in London, where I’ve been learning about a blood test that could substantially speed ...

A 66 per cent-owned subsidiary of ASX-listed Proteomics International Laboratories has picked up a m...

Medical innovator Proteomics International Laboratories is charging into selling mode after locking ...

Researchers in Australia have developed a new blood test that could transform the diagnosis of endom...

ASX-listed Proteomics International Laboratories is gearing up for the global rollout of its revolut...

A groundbreaking prognostic test developed through collaboration between The University of Western A...

Proteomics International Laboratories has launched its breakthrough PromarkerD predictive test for d...

Proteomics International’s PromarkerD blood test has proven to be a step up from current tests in de...

Currently, it can take years to identify this painful gynecological condition. Scientists may have d...

Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has picked up an Australia...

Proteomics International Laboratories can now roll out its precision diabetes-related blood test int...

Perth, Jan 24, 2025 AEST (ABN Newswire) – Proteomics International Laboratories Ltd (ASX:PIQ) Managi...

Australian company nearing world-first blood test for endometriosis

NEW YORK – Diagnostics firm Proteomics International (PIL) plans to launch its proteomic test for en...

A new blood test could turn the tide on lengthy diagnosis times.

A medical technology company in Australia is aiming for a world-first: it wants to launch a blood te...

A medical technology company in Australia is aiming for a world-first: it wants to launch a blood te...

A new and non-invasive way to test early for the often-debilitating condition has been developed by ...

Knowing when an athlete can safely return to training after intense exercise typically relies on coa...

A fingerprick blood test might be able to detect muscle damage and track recovery in elite athletes,...

In a world-first for sports science, OxiDx, a majority-owned subsidiary of ASX-listed biotechnology ...

Australian researchers have made a breakthrough in endometriosis detection amid the development of a...

Australian researchers have developed an “exciting” new blood test which could help diagnose women w...

Endometriosis blood test could reduce diagnosis times and improve care

Proteomics International’s share price surged as much as 24 per cent today on the best volume in mor...

An Australian blood test for endometriosis raises the prospect of a quicker diagnosis of one of the ...

An Australian breakthrough is set to revolutionise treatment for women with endometriosis. A simple ...

Proteomics International has topped up its coffers with a $2.16 million cash boost from Australia’s ...

Proteomics International has reported positive results from the clinical validation study of its Pro...

People living with type 1 diabetes may be able to manage, treat and potentially avoid kidney decline...

Proteomics International Laboratories testing using its “PromarkerD” device that employs a simple bl...

Kidney disease is a serious issue in Australia and globally and yet despite the social and economic ...

As the digitisation of healthcare continues to advance at rapid speed, consumers are increasingly ab...

Proteomics International’s Managing Director Dr Richard Lipscombe was interviewed by Shares in Value...

Proteomics International said Monday that it has signed a deal with Eurobio Scientific for the exclu...

Proteomics International Laboratories has sealed a new deal with medical diagnostics company Eurobio...

Proteomics International Laboratories is escalating its expansion into the European market after app...

Proteomics International Laboratories has announced a partnership with medical device sales agency G...

Having served as Proteomics chief since he-co founded the company in 2001, Dr Richard Lipscombe is u...

A recent study at the university’s Centre for Crop and Disease Management (CCDM) in Western Australi...

Having previously confirmed dieback is resistant to chemical control on crops such as avocados, ston...

“Proteomics International (PIQ) has been awarded over $400,000 in funding to manufacture its predict...

ASX-listed Proteomics has joined forces with England’s revered Oxford University as the medtech cont...

Proteomics International said it has signed a material transfer agreement with the University of Oxf...

Proteomics International Head of Clinical Studies Dr Kirsten Peters was featured on the opening epis...

Proteomics International Laboratories will continue important research and development for its diagn...

Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has been awarded a Europea...

Proteomics International Laboratories is showcasing its latest diagnostic milestones for endometrios...

Dr Richard Lipscombe, Managing Director of Proteomics International (ASX:PIQ), spoke with 2GB’s Heal...

Proteomics International Laboratories has signed a licence agreement to sell its PromarkerD predicti...

Dr Kirsten Peters, Head of Clinical Studies at Proteomics International (ASX: PIQ), was interviewed ...

Proteomics International (ASX:PIQ) featured on Channel 7’s 4pm and 6pm news bulletins discussing Pro...

Dr Richard Lipscombe, Managing Director of Proteomics International (ASX: PIQ), recently featured in...

Proteomics International Laboratories is nudging closer to commercialising its PromarkerD predictive...

Dr Richard Lipscombe, Managing Director of Proteomics International (ASX: PIQ), recently had an inte...

Dr Richard Lipscombe, Managing Director of Proteomics International (ASX: PIQ), was featured on 6PR ...

Proteomics International’s Managing Director, Dr Richard Lipscombe, featured on Channel 9’s 5pm news...

Proteomics International Laboratories’ blood test uses biomarkers to diagnose oesophageal adenocarci...

Proteomics International Laboratories’ (Proteomics International) blood test uses biomarkers – prote...

Proteomics International Managing Director Dr Richard Lipscombe said the prototype test, named Proma...

Proteomics International’s Managing Director, Dr Richard Lipscombe, featured on 6PR Afternoons on th...

Proteomics International Laboratories’ share price has hit a seven-month high after a United States ...

Proteomics International Laboratories soared 13 per cent after its shares came out of voluntary trad...

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the ...

Proteomics International Pty Ltd has developed a new blood-based diagnostic test called the Promarke...

Proteomics International managing director Dr Richard Lipscombe said the technology has the potentia...

Proteomics International Laboratories has revealed new results showing that refinement of its simple...

“We’ve refined our diagnostic models to correctly identify 89 per cent of patients with oesophageal ...

Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has been granted a breakth...

Article: Intervention needed to stop kidney disease overwhelming NHS, charity says

Article: NHS facing ‘impossible’ challenge to care for kidney disease patients, charity says

Article: Kidney disease ‘could become public health emergency’ without more funding, charity warns

Article: Heartbreaking impact of endometriosis on women laid bare

Dr Richard Lipscombe, Managing Director of Proteomics International, spoke with ABN Newswire regardi...

Article: Proteomics International (ASX:PIQ) inks exclusive licence agreement to bring PromarkerD to ...

Article: Proteomics’ PromarkerD test enters the lucrative US market

Article: Proteomics seals exclusive deal for kidney test in US

Proteomics International is pleased to announce it has signed an exclusive licence agreement with So...

We are excited to present the latest results for our potential world’s first non-invasive blood test...

Proteomics International in collaboration with Janssen Research & Development have shown that Promar...

“The new members bring a wealth of knowledge in treating diabetes patients and they will be importan...

We are pleased to announce the appointment of additional members to the Clinical Advisory Board addi...

“To mark the end of Endometriosis Awareness Month, experienced Health Research Associate Dr Kirsten ...

“Proteomics International Laboratories says it has developed a simple new blood test to identify up ...